The Online Investor
Evolus Inc (EOLS)

Evolus is a performance beauty company focused on delivering breakthrough products in the self-pay aesthetic market. Co.'s product, Jeuveau™ (prabotulinumtoxinA-xvfs), is a 900 kDa purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Co.'s primary market is the self-pay aesthetic market, which includes medical products purchased by physicians that are then sold to consumers or used in procedures for aesthetic indications that are not reimbursed by any third-party payor, such as Medicaid, Medicare or commercial insurance.

EOLS SEC Filing Email Alerts Service
Company Name: 
Evolus Inc
Website: 
www.evolus.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding EOLS: 
17
Total Market Value Held by ETFs: 
$21.28M
Total Market Capitalization: 
$390.00M
% of Market Cap. Held by ETFs: 
5.46%
Quotes delayed 20 minutes



Buy (3.25 out of 4)
50th percentile
(ranked higher than approx. 50% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Evolus Inc (EOLS) Page | The Online Investor Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2019, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.